ORAMED PHARMACEUTICALS INC. (ORMP) Capital expenditures 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9,000FY2025 · since FY2016: $9,000 → $9,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9,000 | -50.0% |
| FY2024 | $18,000 | -92.9% |
| FY2023 | $254,000 | -48.8% |
| FY2022 | $496,000 | +32.3% |
| FY2021 | $375,000 | +357.3% |
| FY2020 | $82,000 | +446.7% |
| FY2019 | $15,000 | +200.0% |
| FY2018 | $5,000 | -28.6% |
| FY2017 | $7,000 | -22.2% |
| FY2016 | $9,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice